当茎死亡时，它的激素信号也停止了。
那些患有乳腺癌，同时服用激素的妇女因其他疾病死亡的几率同样比对照组高，每年的死亡率分别是0.05%和0.03%。
Among women who had breast cancer, those who took hormones also had a higher death rate from other causes - 0.05 percent per year, versus 0.03 percent per year.
冈萨雷斯说到：“肾上腺素激素急速上升，越接近死亡，越是让我更加爱的疯狂。”
"Adrenaline rush — the closer I feel to getting killed, the more I love it," Gonzalez said.
一群顶尖的医生目前正在受审，原因是间接注射了人类疯牛病病毒污染的生长激素而导致了117个孩子的死亡。
A group of top doctors are currently on trial for indirectly causing the deaths of 117 children by injecting them with growth hormones tainted with the human form of mad cow disease.
也就是说，10000名服用激素的妇女中有2.6人死亡，而对照组有1.3人死亡，服用激素组是对照组的两倍。
That translates to 2.6 deaths per 10, 000 women per year among those taking hormones, twice the 1.3 deaths per 10, 000 in the placebo group.
“我们惊讶地得到了死亡受体，它不会对任何激素产生反应，因为以前那些同样的状态在蛋白质中只存在很短的时间。”桑顿说道。
"We were surprised to get a dead receptor that wouldn't respond to any hormones, because those same states had existed in the protein a relatively short time before," says Thornton.
这是妇女健康倡议发表的包含和激素使用有关的由乳腺癌导致的死亡率的第一篇报告。
It is the first report from the Women's Health Initiative that includes death rates from breast cancer related to hormone use.
日内瓦大学的研究员提问：如果雌激素升高会加速癌症死亡，是否抗雌激素会起到相反的作用呢？
The researchers at the University of Geneva asked if increasing oestrogen increased cancer deaths, would reducing oestrogen have the opposite effect.
这一结果发表在《癌症期刊》，表明抗雌激素减少肺癌患者的死亡人数。
The study, published the cancer Journal, showed that anti-oestrogens reduced the number of deaths from lung cancer.
女性患有肺癌的数量没有差别，但是服用抗雌激素药物的死亡率更低一些。
There was no significant difference in the number of women developing lung cancer, but those on anti-oestrogens did have a lower death rate.
服用激素且死于乳腺癌的妇女比对照组多，每年的死亡率分别为0.03%和0.01%。
More women who took hormones died from breast cancer - 0.03 percent per year, versus 0.01 percent per year in the placebo group.
死亡率增加的原因可能是由于雌激素刺激新血管生长——导致癌症发生或扩散。
The reason for the increased mortality could be oestrogen stimulating the growth of new blood vessels - which can cause the cancer to grow and spread.
每10 000个女性在她们70岁左右的时候，使用雌激素之后，有16个额外心脏病概率，19个意外死亡以及48个重大的不良事件。
For every 10, 000 women in their 70s, using estrogen would cause 16 extra heart attacks, 19 extra deaths and 48 serious adverse events.
不管癌症处于何种临床病理阶段，与化疗或激素疗法相关的复发及死亡危险的相对减少都是一样的。
Relative reduction in risk of recurrence and death associated with chemotherapy or hormone therapy is the same regardless of the clinical-pathologic stage of the cancer.
换句话说，就是每10000名妇女中每年的死亡人数分别为5.3和3.4人，服用激素组高出1.9人。
In other words, there were 5.3 versus 3.4 deaths per 10, 000 women per year - 1.9 extra deaths in hormone users.
合并心脏疾病的人中，经调整其他危险因素后，用激素治疗有高出96%的死亡风险。
Among those with heart problems, the hormone treatment was linked to a 96% higher risk of death after adjusting for other risk factors.
在原始数据里，用激素治疗的男性中也有95%存在严重的心脏病史，25名死亡。
In raw Numbers, of the 95 men on hormone therapy who also had a history of serious heart problems, 25 died.
在161名未用激素治疗的男性也有心脏病史，18名死亡。
Of the 161 men not on hormone therapy who also had a history of heart problems, 18 died.
结论：糖皮质激素可以使造成海水淹溺者死亡的主要原因得以控制，取得满意的疗效。
Conclusion the Dexamethasone can controll the main causes of death of the drowning and obtain satisfactory curative effect.
这个研究提出与普通人群相比使用生长激素治疗有增加死亡率的风险。
The study results suggest an increased risk of mortality with somatropin therapy compared to the general population.
目的：本研究目的是总结我们所知道的促肾上腺皮质激素依赖性库欣病的死亡率，报告我们的数据，并对其他六项关于库欣病死亡率的报告进行荟萃分析。
Objective: The aim was to summarize what is known about mortality in ACTH-dependent CD, to report on our own data, and to provide a meta-analysis of six other reports that addressed mortality of CD.
在病原、诱发因子和激素应答中是调节细胞程序性死亡的关键因子。
It is the key factor regulating programmed cell death in pathogen, evocator and hormone responses.
目的：本研究目的是总结我们所知道的促肾上腺皮质激素依赖性库欣病的死亡率，报告我们的数据，并对其他六项关于库欣病死亡率的报告进行荟萃分析。
The aim was to summarize what is known about mortality in ACTH-dependent CD, to report on our own data, and to provide a meta-analysis of six other reports that addressed mortality of CD.
在此模型中，更高的临床肿瘤分级及雌激素受体阴性与远处复发或死亡存在具有显著统计学差异的相关性。
In this model, higher clinical tumor stage and ER-negative status were associated with a statistically significantly greater risk for distant relapse or death.
此外，通过对该实验继续研究2.4年(共8年的监测)的结果显示，激素疗法会增加肺癌的死亡率。
In addition, results from further follow-up of an additional 2.4 years (totalling 8 years of monitoring) suggested that the combined hormone therapy might increase mortality from lung cancer.
患严重肥胖或严重呼吸损伤的帕-魏二氏综合症，并使用生长激素治疗患者中，有死亡病例的报导。
Deaths have been reported in patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment and are treated with somatropin.
结果98例经糖皮质激素治疗的患者，有21例发生深部真菌感染，其中2例患者死亡。
Results 21 cases of 98 patients suffered from deep fungous infection and 2 patients died during the treatment.
肺癌是女性癌症相关的死亡的一种主要原因。激素替代治疗(HRT)在肺癌中的作用还不清楚。
Purpose lung cancer is the leading cause of cancer-related mortality among women. The role of hormone replacement therapy (HRT) in lung cancer development is unclear.
这类肿瘤是该疾病的致命类型，多数病人在对激素抑制产生抗性后18 -24个月死亡。
This type of the cancer is a lethal form of the disease, with most patients dying 18 to 24 months after becoming resistant to hormone suppression.
结果：20例符合抗利尿激素分泌异常综合征，其中治愈18例，死亡2例；
Results: Syndrome of inappropriate antidiuretic hormone was found in 20 cases, with which 18 patients were cured and 2 patients died.
应用推荐